The $2.6 billion pill - Methodologic and policy considerations

New England Journal of Medicine

Volumn 372, Issue 20, 2015, Pages 1877-1879

  Avorn, Jerry ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

CONFERENCE PAPER; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; FUNDING; GOVERNMENT; HEALTH CARE POLICY; METHODOLOGY; PRIORITY JOURNAL; DRUG APPROVAL; DRUG DEVELOPMENT; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE COST; NATIONAL HEALTH ORGANIZATION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

CAPITAL EXPENDITURES; DRUG APPROVAL; DRUG COSTS; DRUG DISCOVERY; DRUG INDUSTRY; FINANCING, GOVERNMENT; NATIONAL INSTITUTES OF HEALTH (U.S.); RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 84929359137     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1500848     Document Type: Conference Paper

References (5)

1. How the Tufts Center for the Study of Drug Development pegged the cost of a new drug at $2.6 billion. Boston: Tufts Center for the Study of Drug Development, November 18, 2014 (http://csdd.tufts.edu/files/uploads/cost-study-backgrounder.pdf).
2. Biotechnology Industry Organization. BIO response to the Alexander-Burr Report. February 23, 2015 (https://www.bio.org/sites/default/files/2015-02-23%20BIO%20 Response%20to%20Alexander%20and%20 Burr.pdf).
3. Phillips R, Wamhoff S, Smith D. Offshore shell games: the use of offshore tax havens by Fortune 500 companies. Washington, DC: Citizens for Tax Justice, U. S. PIRG Education Fund, June 2014 (http://uspirgedfund.org/sites/pirg/files/reports/OffshoreShellGames USPIRG-CTJ.pdf).
4. Kesselheim AS, Tan YT, Avorn J. The roles of academia, rare diseases, and repurposing in the development of the most transformative drugs. Health Aff (Millwood) 2015;34:286-93.
5. Kaiser J. Largest U. S. biomedical research society weighs in on NIH's budget woes. Science Insider. January 9, 2015 (http://news.sciencemag.org/biology/2015/01/largest-u-s-biomedical-research-society-weighs-nih-s-budget-woes).